Funding profile · Health IT and revenue cycle
Datrics
A Y Combinator seed round from 2021 is still the only financing this company has ever disclosed. No SEC filing exists for it, and no new round has been reported since, even as the company rebrands around healthcare claims coding.
Data as of September 25, 2026. Company-reported figures are labeled.
Rounds at a glance
| When | Round | Amount | Investors | Source |
|---|---|---|---|---|
| Before 2021 | Early backing | Undisclosed, plus $200,000 | ICU Ventures (undisclosed amount); QPDigital ($200,000) | Independent |
| Jan 2021 | Y Combinator, Winter 2021 | $125,000 | Y Combinator | Independent |
| Aug 2021 | Seed | $1M+ announced | Y Combinator, Altair Capital, ICU Ventures, Illia Polosukhin, Oleg Roginsky, Nick Belogorsky and other angels | Company release |
| As of 2026 | Cumulative total, third party | $1.5M | Not broken out; round staged as Seed | Aggregator |
| Not found | Series A or later | Not disclosed | None announced | Not found |
What the filings show
Nothing. A full text search of SEC EDGAR for “Datrics” and for “datrics.ai” returns zero results across every filing type, not just Form D. A separate search of EDGAR’s company database for an entity named Datrics also returns no match. Every dollar figure attached to this company, the Y Combinator allocation, the 2021 seed round, and the third party total, comes from a company announcement, an accelerator record, or a private data aggregator, not from a federal filing.
The one document that is a public record is not a securities filing. Bloomberg’s Legal Entity Identifier registry shows Datrics, Inc. as a Delaware corporation, registered May 6, 2020, with a San Francisco business address at 880 Harrison Street, Suite 202. That confirms the entity exists and when it was formed. It says nothing about how much money it has raised or from whom.
Reading the money trail
- No Form D means no federal check on any of these numbers.Companies that raise under Section 4(a)(2) instead of Regulation D file no Form D at all, so the absence does not prove no money moved. It does mean none of the figures below, the $125,000 YC allocation, the “$1M+” seed, or the $1.5M cumulative total reported by a third party aggregator, can be checked against anything the SEC has on file.
- The public number is not consistent.The company announced “$1+ million” in August 2021. A third-party company database puts total raised at about $1.5 million with the round staged as Seed. Neither source explains the $0.5M gap, and no later announcement closes it.
- The same investor appears on both sides of the company’s story.Illia Polosukhin, an angel investor in the 2021 seed round, is a co-founder of NEAR, the protocol Datrics partnered with in December 2025 to build TravAI, a travel booking platform. There is no Form D to source a related-persons field from, but the overlap between an early investor and a later commercial partner is worth flagging on its own.
- The legal entity has a paper trail even without a securities filing.The Legal Entity Identifier record ties the Datrics brand to a specific Delaware corporation with a San Francisco address, registered the same month AIN reported the company was founded. As of the most recent renewal check in the record, its registration status was listed as lapsed.
- Nothing has been reported since 2021.No Series A, bridge round, or new institutional investor has been announced for either the original analytics business or the newer Datrics HCP healthcare product. If the healthcare pivot has been separately capitalized, that has not surfaced in any public source found for this profile.
Commercial signals
| Signal | Detail | Source type |
|---|---|---|
| Accelerator | Y Combinator, Winter 2021 batch. Separate incubation support from Sigma Software Labs in Ukraine, announced 2021. | Independent |
| Revenue | A private company database estimates annual revenue of about $2.1 million. Not confirmed by any filing or company disclosure. | Unverified estimate |
| Headcount | A private company database lists about 21 employees. Not confirmed independently. | Unverified estimate |
| Named customers | None named for the healthcare product. The 2021 seed announcement named Revolut as a banking and fintech client of the earlier analytics platform. | Not found |
| Second business line | TravAI, an AI agent and blockchain travel booking platform built with NEAR Protocol and ADI Chain, announced December 2025. No funding details disclosed for it. | Independent |
What to watch
- Any Form D filing under Datrics, Inc. or a related entity name, which would be the first SEC record this company has produced.
- Whether the Legal Entity Identifier is renewed, since its status was recorded as lapsed.
- Named customers or disclosed revenue for Datrics HCP specifically, separate from the older analytics business.
- Whether TravAI raises its own capital or stays a partnership project inside Datrics.
The Datrics story on Healthcare DiscoveryHealthcare Discovery
Related companies
Sources
- Public recordDatrics, Inc. Legal Entity Identifier record, LEI 984500AD2ACD9Y94F903
- Public recordSEC EDGAR full text search for Datrics and for datrics.ai
- Public recordSEC EDGAR company search for Datrics
- IndependentUkrainian Datrics raises funds from YCombinator
- InvestorICU invests in Ukrainian no-code data analysis and machine learning platform Datrics
- CompanyDatrics $1M Seed announcement
- CompanySigma Software Labs and datrics.ai developing Ukrainian tech business together
- IndependentDatrics company and funding listing
- IndependentDatrics.ai Company Profile, Management and Employees List
- IndependentADI Foundation and Datrics Partner With NEAR on TravAI, an AI and Blockchain-Powered Travel Platform
- CompanyDatrics: Generative AI Healthcare Coding Automation, company page
Compiled from SEC, Bloomberg LEI and other public records and published reports as of September 25, 2026. No Form D or other SEC filing was found under the name Datrics as of this date. Amounts described as company-reported or third-party reported have not been verified against a federal filing. Healthcare Venture Capital Fund holds no position in Datrics. This page is not an offer to sell or a recommendation to buy any security.
